Mindset Pharma Inc. competitors & alternatives

DENOVO SCIENCES, INC.Biotechnology & PharmaceuticalsUnited States

64% matchPrivate

Biotechnology & Pharmaceuticals

Denovo Sciences Inc. is an AI-driven drug discovery company developing proprietary technologies and automated systems for early-stage small-molecule discovery and single-cell analysis. The company has collaborated with international partners to address unmet medical needs.

NYB Holdings LtdNYB · Biotechnology & PharmaceuticalsUnited States

63% matchPublic

Biotechnology & Pharmaceuticals

NYB Holdings Ltd operates an AI-first drug discovery and biotechnology platform that utilizes a large natural compound library and predictive modeling to identify bioactive compounds. The company develops science-backed wellness solutions for nutraceutical applications and advances high-potential drug candidates into preclinical development for the pharmaceutical industry.

Gilgamesh Pharma Inc.BiotechnologyUnited States

71% match

Biotechnology

Gilgamesh Pharma Inc. is a clinical-stage neuroscience company that develops novel chemical entities to treat psychiatric diseases, aiming to move beyond symptom management toward rapid-acting and durable therapies. The company utilizes an AI-powered discovery platform and medicinal chemistry to create precision therapies targeting conditions such as depression, anxiety, addiction, and schizophrenia.

Sharp Therapeutics Corp.SHRX · BiotechCanada

67% matchPublic

Biotech

Sharp Therapeutics Corp. is a preclinical-stage biotechnology and drug discovery company that develops small molecule therapies to treat genetic diseases and hereditary disorders. The company combines high-speed experimentation and computational methods to advance its drug discovery platform.

Daya CNS, LLCBiotechnologyUnited States

67% matchPrivate

Biotechnology

Daya CNS, LLC is a preclinical biopharmaceutical company that develops a proprietary non-opioid pyridoindole platform for the treatment of chronic pain, substance abuse disorders, and neuropsychiatric conditions. Its product pipeline includes small molecule medications such as DDD-028 for neuropathic and inflammatory pain, DDD-024 for addiction, and DDD-016 for neuropsychiatric disorders, serving patients with unmet medical needs in neurology and addiction medicine.

Biotechnology

Minerva Biotechnologies Corp. is a biotechnology holding company based in Woburn, Massachusetts, engaged in drug pipelines and patent development.

Mesentech Inc.BiotechnologyCanada

66% matchPrivate

Biotechnology

Mesentech Inc. is an active for-profit biotechnology company focused on drug pipelines, therapeutic areas, and proprietary technology platforms. Headquartered in Vancouver, British Columbia, Canada, the company operates with a small team specializing in clinical research and development.

Biotech

Alto Neuroscience, Inc. operates as a biopharmaceutical entity in the clinical stage, specializing in the creation of novel psychiatric medications. Its development pipeline includes ALTO-100, an investigational therapy targeting individuals affected by major depressive disorder (MDD) and post-traumatic stress disorder. Also in its portfolio is ALTO-300, a small molecule designed to function as both a melatonergic agonist and serotonergic antagonist, exhibiting antidepressant properties for MDD patients. For addressing the cognitive impairments linked with schizophrenia, Alto Neuroscience is advancing ALTO-101, an innovative small molecule phosphodiesterase 4 inhibitor. The company's therapeutic candidates further extend to ALTO-203, a pioneering small-molecule histamine H3 receptor inverse agonist intended for MDD patients experiencing heightened anhedonia, and ALTO-202, an orally available antagonist of the GluN2B subunit of the NMDA receptor, also under investigation for MDD. Beyond these individual drug candidates, the firm is engaged in developing novel drug combinations that demonstrate synergistic pharmacodynamic effects. Crucially, Alto Neuroscience leverages an advanced AI-enabled biomarker platform that synthesizes data concerning patients' brain activity and behavioral patterns. This platform's purpose is to accurately identify which individuals are most likely to respond positively to its cutting-edge product candidates. Alto Neuroscience, Inc., established in 2019, maintains its headquarters in Los Altos, California.

Life Sciences

KisoJi Biotechnology Inc. is a drug discovery company headquartered in Montreal, Canada, utilizing a proprietary antibody discovery platform to create next-generation antibody drugs.

ImStarLife SciencesCanada

65% match

Life Sciences

ImStar Therapeutics Inc. is a biotechnology company headquartered in Vancouver, British Columbia, focused on breakthrough science and drug discovery.

MironidBiotechUnited Kingdom

65% match

Biotech

Mironid Limited is a privately held drug discovery company founded in 2015 and headquartered in Glasgow, Scotland. The patient-focused company develops innovative therapeutics to improve the treatment of various medical conditions.

Healthcare

NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that develops therapeutics for central nervous system disorders. Its pipeline focuses on treating conditions such as suicidal depression, suicidal bipolar depression, and post-traumatic stress disorder. The company utilizes a proprietary NMDA platform for its therapeutic developments.